ClinicalTrials.Veeva

Menu

Differential Study of Muscle Transcriptome (TRANE)

A

Assistance Publique - Hôpitaux de Paris

Status

Completed

Conditions

ALS
SBMA
SMA

Treatments

Procedure: Muscle biopsy

Study type

Interventional

Funder types

Other

Identifiers

NCT01984957
P110401

Details and patient eligibility

About

To isolate biomarkers of ALS in muscle

Full description

At present, there is no validated biological diagnostic marker for amyotrophic lateral sclerosis (ALS). The main objective of the study is to isolate a set of genes that are specifically dysregulated in muscle from ALS patients.

Gene profiling in muscle will be compared between ALS patients and patients with other motor neuron diseases (SMA and SBMA)

Enrollment

42 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria :

  • Patient with ALS, SMA, or SBMA

Exclusion criteria :

  • Indication against biopsy (allergy to anesthetics local haemostasis disorders)
  • Treatments that can affect muscle metabolism

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

42 participants in 1 patient group

disease (ALS, SMA or SBMA)
Other group
Description:
muscle biopsy
Treatment:
Procedure: Muscle biopsy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems